• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱T2、3期癌,NXM0,先进行40Gy外照射,随后以降低剂量(50%)进行铯137植入治疗。

Carcinoma of the urinary bladder category T2,3NXM0 treated by 40 Gy external irradiation followed by cesium137 implant at reduced dose (50%).

作者信息

van der Werf-Messing B H, van Putten W L

机构信息

Dr. Daniel den Hoed Kliniek & Rotterdamsch Radio-Therapeutisch Instituut, The Netherlands.

出版信息

Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):369-71. doi: 10.1016/0360-3016(89)90332-5.

DOI:10.1016/0360-3016(89)90332-5
PMID:2921141
Abstract

Forty-eight bladder cancers T2NXM0 with bad prognostic factors and 42 T3NXM0 growths, suitable for interstitial treatment, were submitted to 40 Gy external irradiation immediately followed by Cae137 Implant at "reduced dose". Intercurrent death corrected 5-year survival for both groups was about 80%. The influence of previously identified bad prognosticators (more than one TUR, WHO grade 3, 4, vascular invasion in the biopsy specimen, pathological IVP) was nearly eradicated.

摘要

48例具有不良预后因素的膀胱T2NXM0期癌和42例适合间质治疗的T3NXM0期肿瘤,先接受40Gy外照射,随后立即给予“低剂量”的铯137植入。两组的并发死亡校正5年生存率约为80%。先前确定的不良预后因素(不止一次经尿道切除术、世界卫生组织3级、4级、活检标本中的血管侵犯、病理静脉肾盂造影)的影响几乎被消除。

相似文献

1
Carcinoma of the urinary bladder category T2,3NXM0 treated by 40 Gy external irradiation followed by cesium137 implant at reduced dose (50%).膀胱T2、3期癌,NXM0,先进行40Gy外照射,随后以降低剂量(50%)进行铯137植入治疗。
Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):369-71. doi: 10.1016/0360-3016(89)90332-5.
2
Cancer of the urinary bladder category T2, T3, (NxMo) treated by interstitial radium implant: second report.经间质镭植入治疗的膀胱T2、T3期癌症(NxMo):第二次报告
Int J Radiat Oncol Biol Phys. 1983 Apr;9(4):481-5. doi: 10.1016/0360-3016(83)90064-0.
3
T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy.膀胱T1和T2期癌:外照射、术前放疗或组织间放疗的长期结果
Int J Radiat Oncol Biol Phys. 1992;23(2):299-304. doi: 10.1016/0360-3016(92)90745-4.
4
Carcinoma of the urinary bladder: long-term results of interstitial radiotherapy.膀胱癌:间质放疗的长期结果
Bull Cancer Radiother. 1994;81(1):33-40.
5
Factors influencing the prognosis in bladder cancer.影响膀胱癌预后的因素。
Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):559-65. doi: 10.1016/0360-3016(86)90063-5.
6
Carcinoma of the urinary bladder category T3NxMo treated by the combination of radium implant and external irradiation: second report.镭植入联合外照射治疗T3NxMo期膀胱癌:第二次报告
Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):177-80. doi: 10.1016/0360-3016(83)90095-0.
7
Bladder cancer. The selection of patients for treatment by full-dose irradiation.膀胱癌。全剂量照射治疗患者的选择。
Cancer. 1985 May 1;55(9 Suppl):2278-84. doi: 10.1002/1097-0142(19850501)55:9+<2278::aid-cncr2820551435>3.0.co;2-#.
8
Outpatient template-guided permanent interstitial brachytherapy using Cs in gynecologic malignancies: Initial report.门诊模板引导下使用铯进行妇科恶性肿瘤的永久性组织间近距离放疗:初步报告。
Brachytherapy. 2017 Mar-Apr;16(2):393-401. doi: 10.1016/j.brachy.2016.12.008. Epub 2017 Jan 27.
9
Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.低剂量率近距离放射治疗在膀胱癌治疗方面优于高剂量率近距离放射治疗。
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):696-705. doi: 10.1016/j.ijrobp.2003.11.040.
10
Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies.利用 Cs-131 永久性间质植入治疗妇科恶性肿瘤的实施和初步临床结果。
Gynecol Oncol. 2014 May;133(2):268-73. doi: 10.1016/j.ygyno.2014.02.015. Epub 2014 Feb 17.

引用本文的文献

1
Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review.近距离放射治疗在膀胱癌保留器官治疗中的长期作用:历史回顾
J Contemp Brachytherapy. 2020 Dec;12(6):618-628. doi: 10.5114/jcb.2020.101697. Epub 2020 Dec 16.
2
Robot-assisted brachytherapy of the bladder with long distance support using video conferencing.使用视频会议进行远程支持的机器人辅助膀胱近距离放射治疗。
J Contemp Brachytherapy. 2017 Aug;9(4):375-382. doi: 10.5114/jcb.2017.69548. Epub 2017 Aug 30.
3
Bladder preservation with brachytherapy compared to cystectomy for T1-T3 muscle-invasive bladder cancer: a systematic review.
与膀胱切除术相比,近距离放射治疗用于T1-T3期肌层浸润性膀胱癌的膀胱保留:一项系统评价。
J Contemp Brachytherapy. 2014 Jun;6(2):191-9. doi: 10.5114/jcb.2014.43777. Epub 2014 Jun 28.
4
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).随机非劣效性试验:对于肌层浸润性膀胱癌,低剂量大体积放疗与标准剂量体积放疗的比较:BC2001 试验(CRUK/01/004)结果。
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):261-9. doi: 10.1016/j.ijrobp.2013.06.2044.